Last updated: February 26, 2025
Sponsor: Aswan University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hemodialysis
Treatment
Stellate ganglion block
Clinical Study ID
NCT06300658
900/2/24
Ages 21-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 21 to 75 years.
Both sexes.
American Society of Anesthesiologists (ASA) physical status III.
Chronic renal failure (CRF) patients.
Undergoing major lower limb orthopedic surgery.
Exclusion
Exclusion Criteria:
Psychiatric disorders.
History of substance abuse.
Ipsilateral brachial and radial artery stenosis.
Allergy to local anesthetics.
Cardiovascular and respiratory disorders.
Coagulopathy.
Use of vasoactive medications.
Obesity (body mass index >30 kg/m2).
Smoking.
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Stellate ganglion block
Phase:
Study Start date:
March 09, 2024
Estimated Completion Date:
February 28, 2025
Study Description
Connect with a study center
Aswan University
Aswan, 81528
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.